While taking into account that RA progression in joints affects also adjacent bones, we further performed an in vitro evaluation of functional contribution of IL-6 and TNFα on the inhibition of bone formation using treatment with recombinant cytokines combined with a blocking of IL-6 expression by shRNA in mouse mesenchymal precursor cells of C2C12. The gene discussed is IL6; the disease is rheumatoid arthritis.